1-5 of 5
Maria C. Foss Freitas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

2123-LB: Discovery of CERS2 Haploinsufficiency Causing Atypical Lipodystrophy and Severe Fatty Liver Disease—Utility of Multiomics Analyses in the RADIANT study

Free
MARIA C. FOSS-FREITAS, AHMED ALKANAQ, CASEY THORNTON, DAVID BROOME, DONATELLA GILIO, LIPING WANG, CHIKA UWANDU, ANABELA DILL GOMES, ASHOK BALASUBRAMANYAM, SCOTT A. SUMMERS, ELIF A. ORAL
Journal: Diabetes
Diabetes 2024;74(Supplement_1):2123-LB
https://doi.org/10.2337/db25-2123-LB
Published: 20 June 2025
View articletitled, 2123-LB: Discovery of CERS2 Haploinsufficiency Causing Atypical Lipodystrophy and Severe Fatty Liver Disease—Utility of Multiomics Analyses in the RADIANT study
Meeting Abstracts

1402-P: Novel Lipodystrophy Genotype Correlations Identified through the Rare and Atypical Diabetes Network (RADIANT)

Free
DAVID BROOME, MARIA C. FOSS-FREITAS, ANIKO SABO, ZEB I. SAEED, MIRIAM UDLER, TONI I. POLLIN, JASON FLANNICK, KRISTIN A. MALONEY, DONATELLA GILIO, MERVE CELIK GULER, DIARRATOU KABA, ANABELA DILL GOMES, JENNIFER POSEY, MUSTAFA TOSUR, STEPHEN I. STONE, RAYMOND J. KREIENKAMP, IRL B. HIRSCH, JOSE C. FLOREZ, ASHOK BALASUBRAMANYAM, LOUIS H. PHILIPSON, CATHERINE PIHOKER, ELIF A. ORAL, RADIANT STUDY GROUP
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1402-P
https://doi.org/10.2337/db24-1402-P
Published: 14 June 2024
View articletitled, 1402-P: Novel Lipodystrophy Genotype Correlations Identified through the Rare and Atypical Diabetes Network (RADIANT)
Meeting Abstracts

1875-LB: Adjuvant Glucagon-Like Peptide 1 Receptor Agonist (GLP-1 RA) Use in HNF1A- and HNF4A-MODY

Free
DAVID BROOME, ALINA Z. MEHDI, MARIA C. FOSS-FREITAS, COLBY CHASE, BRIGID GREGG, ELIF A. ORAL, WILLIAM H. HERMAN
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1875-LB
https://doi.org/10.2337/db24-1875-LB
Published: 14 June 2024
View articletitled, 1875-LB: Adjuvant Glucagon-Like Peptide 1 Receptor Agonist (GLP-1 RA) Use in HNF1A- and HNF4A-MODY
Meeting Abstracts

313-OR: The Efficacy and Safety of Glucagon-Like-Peptide-1 Agonists in Patients with Familial Partial Lipodystrophy

Free
SALMAN K. IMAM, MARIA C. FOSS-FREITAS, RASIMCAN MERAL, ELIF A. ORAL, ANABELA DILL GOMES, FATIHA GRISSI
Journal: Diabetes
Diabetes 2023;72(Supplement_1):313-OR
https://doi.org/10.2337/db23-313-OR
Published: 20 June 2023
View articletitled, 313-OR: The Efficacy and Safety of Glucagon-Like-Peptide-1 Agonists in Patients with Familial Partial Lipodystrophy
Journal Articles

Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2

Free
Callie A.S. Corsa, Carolyn M. Walsh, Devika P. Bagchi, Maria C. Foss Freitas, Ziru Li, Julie Hardij, Katrina Granger, Hiroyuki Mori, Rebecca L. Schill, Kenneth T. Lewis, Jessica N. Maung, Ruth D. Azaria, Amy E. Rothberg, Elif A. Oral, Ormond A. MacDougald
Journal: Diabetes
Diabetes 2021;70(9):1970–1984
https://doi.org/10.2337/db20-1001
Published: 04 June 2021
View articletitled, Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2
Open the PDF for Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2 in another window